INSIGHTS ON DRUG DEVELOPMENT

• Assessing Particle Generation In A Single-Use Mixing System

  Explore how particle levels remained stable during 24 hours of high-speed mixing, even under extreme temperatures, confirming a system’s suitability for final fill and other particulate-sensitive applications.

• How Patent Expirations Will Reshape The Dry Powder Inhaler (DPI) Market

  Patent expirations on dry powder inhalers are driving rapid market competition. Discover how optimized mechanical dosing speeds scale-up and protects profit margins.

• Molecular Properties Of PROTACs And The Relationship To Formulation Design

  Here, we conduct a comprehensive analysis of diverse PROTAC (Proteolysis Targeting Chimeras) structures, evaluating their calculated physicochemical properties to identify key trends.

• Characterizing Quality Attributes Of GLP-1 Analogs By Light Scattering

  Explore how light scattering reveals the structural integrity, aggregation, and stability of GLP-1 analogs to advance drug formulation and enhance treatment efficacy for type 2 diabetes and obesity.

• In Vivo Testing Of Nasal Dosage Forms

  5/7/2025

  Innovative nasal drug delivery strategies can unlock faster, patient-friendly therapeutic solutions by combining smart formulation, advanced testing platforms, and rigorous preclinical evaluation.

• Accelerating Development With Rapid Delivery Of Toxicological Study Material

  3/19/2025

  Explore key strategies and technologies designed to address the analytical considerations and material flows to facilitate the rapid delivery of toxicological material.

• Enabling Flexibility And Scientific Innovation In OSD Development

  8/31/2026

  How one clinical-stage CNS biotech navigated early formulation complexity, shifting pipeline priorities, and scalable manufacturing demands through a strategic CDMO partnership.

• AAV Downstream Challenges: Expert Insights

  5/22/2025

  Gain expert insight into the complexities of AAV purification to learn how industry leaders tackle downstream challenges, optimize workflows, and drive innovation in scalable, efficient gene therapy manufacturing solutions.

• API Solubility And Dissolution Enhancement Via Formulation

  6/4/2025

  Solubility and dissolution rate of an API are essential for effective oral drug absorption. Discover how these factors directly influence bioavailability, which determines how much and how quickly a drug enters circulation.